Zoster ophthalmicus eye redness - Causes, Treatment & When to See a Doctor

```html

What is Zoster ophthalmicus eye redness?

Zoster ophthalmicus (ZO) is a manifestation of the varicella‑zoster virus (VZV) that reactivates in the ophthalmic branch of the trigeminal nerve (cranial nerve V‑1). When the virus involves ocular structures, the most noticeable external sign is a vivid, often painful redness of the conjunctiva and sclera. The redness results from inflammation of the ocular surface (conjunctivitis), episcleral vessels (episcleritis), or deeper involvement such as keratitis and uveitis. Because the eye is a delicate organ, ZO can quickly progress to vision‑threatening complications if not identified and treated promptly.

According to the Mayo Clinic, approximately 10‑20 % of individuals who develop shingles will experience ophthalmic involvement, and the risk rises sharply in people over 60 years of age or those with weakened immune systems.

Common Causes

Eye redness that is specifically linked to zoster ophthalmicus can arise from several related processes. The table below lists the most frequent underlying causes, both viral and non‑viral, that clinicians consider when evaluating a patient with a red eye in the setting of shingles.

• Reactivation of varicella‑zoster virus in the ophthalmic (V1) division of the trigeminal nerve
• Herpes simplex virus (HSV) keratitis – can mimic VZV inflammation
• Secondary bacterial conjunctivitis (often superimposed on viral inflammation)
• Corneal ulceration secondary to VZV epithelial breakdown
• Uveitis (anterior or posterior) caused by VZV
• Episcleritis or scleritis from inflammatory spread
• Acute dacryocystitis (inflammation of the lacrimal sac) that may accompany VZV lesions
• Immune‑mediated stromal keratitis (post‑herpetic)
• Neurotrophic keratopathy due to trigeminal nerve damage
• Drug‑induced ocular redness (e.g., topical steroids used for inflammatory control)

Associated Symptoms

Eye redness in ZO rarely occurs in isolation. The following signs and symptoms frequently accompany the redness and help distinguish it from more benign causes of a pink eye.

• Dermatomal rash – painful vesicles on the forehead, upper eyelid, or tip of the nose (Hutchinson sign).
• Eye pain – a deep, burning sensation that may worsen with eye movement.
• Photophobia – heightened sensitivity to light.
• Blurred or decreased vision – especially if the cornea or internal eye structures are involved.
• Tearing and discharge – watery or mucopurulent secretions.
• Swelling of the eyelids (blepharitis) and periorbital edema.
• Foreign‑body sensation – caused by corneal epithelial defects.
• Headache or facial numbness – reflecting trigeminal nerve irritation.

When to See a Doctor

Because ZO can lead to permanent visual loss, prompt medical evaluation is essential. Seek professional care if you notice:

• Redness accompanied by a painful, blistering rash on the forehead, scalp, or nose.
• Any decrease in visual acuity, double vision, or new “floaters.”
• Severe eye pain that does not improve with over‑the‑counter lubricants.
• Photophobia that limits daily activities.
• Rapidly increasing swelling or discharge from the eye.
• History of immune compromise (e.g., chemotherapy, HIV, organ transplant).

Diagnosis

Diagnosis of Zoster ophthalmicus with eye redness is primarily clinical but may be supported by laboratory testing.

History and Physical Examination

• Detailed symptom timeline (onset of rash, eye pain, vision changes).
• Inspection for the classic “Hutchinson sign” – vesicles on the tip of the nose, indicating nasociliary branch involvement and higher risk of ocular disease.
• Slit‑lamp examination by an ophthalmologist to assess conjunctiva, cornea, anterior chamber, and intra‑ocular pressure.

Laboratory Tests

• Polymerase chain reaction (PCR) of lesion fluid – highly sensitive for VZV DNA.
• Direct fluorescent antibody staining of vesicle scrapings.
• Serology is rarely needed but may be used in immunocompromised patients.

Imaging (when indicated)

• Anterior segment optical coherence tomography (OCT) to evaluate corneal thickness.
• Fundus photography or fluorescein angiography if posterior segment involvement is suspected.

Treatment Options

Management combines antiviral therapy, anti‑inflammatory agents, and supportive eye care. Early treatment (ideally within 72 hours of rash onset) reduces the risk of complications.

Antiviral Medications

• Acyclovir 800 mg five times daily for 7‑10 days.
• Valacyclovir 1 g three times daily (more convenient dosing).
• Famciclovir 500 mg three times daily.
• Intravenous acyclovir is reserved for severe ocular disease or immunocompromised patients.

All antiviral agents are recommended by the CDC for ZO.

Anti‑Inflammatory Therapy

• Topical corticosteroid drops (e.g., prednisolone acetate) under ophthalmic supervision to control stromal keratitis or uveitis.
• Non‑steroidal anti‑inflammatory drug (NSAID) eye drops for milder conjunctival inflammation.
• Systemic steroids may be added for severe scleritis or posterior segment involvement, always in conjunction with antiviral coverage.

Supportive Eye Care

• Preservative‑free artificial tears every 2‑4 hours to maintain surface lubrication.
• Cold compresses to reduce eyelid swelling.
• Topical antibiotic ointment (e.g., erythromycin) if secondary bacterial infection is suspected.
• Protective sunglasses to lessen photophobia.
• Contact lens wearers should discontinue use until the epithelium fully heals.

Follow‑up

Patients should be re‑examined within 48‑72 hours of starting therapy, then weekly until the ocular inflammation resolves. An ophthalmologist will monitor for late complications such as post‑herpetic corneal scarring or glaucoma.

Prevention Tips

While anyone who has had chickenpox can develop shingles, certain measures markedly lower the risk of Zoster ophthalmicus and its ocular sequelae.

• Shingles vaccination – The recombinant zoster vaccine (Shingrix) is >90 % effective in adults ≥50 years and is recommended by the CDC.
• Maintain good hand hygiene and avoid touching facial lesions.
• Promptly treat any shingles rash that appears on the face with antivirals.
• Manage chronic conditions (diabetes, HIV, malignancy) that suppress immunity.
• Stay up to date with routine vaccinations (influenza, COVID‑19) that help preserve overall immune health.
• Limit exposure to stressors and ensure adequate sleep – chronic stress can precipitate VZV reactivation.

Emergency Warning Signs

---

© 2026 HealthInfo Solutions. Content reviewed by board‑certified ophthalmologists and based on guidelines from the Mayo Clinic, CDC, NIH, WHO, and peer‑reviewed journals.

```